Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Yoshimasa Miyagawa · SciRah

Researcher profile · Semantic Scholar

Yoshimasa Miyagawa

Share profile

Yoshimasa Miyagawa — researcher profile on SciRah

h-index: 15
Works: 38
Citations: 589

Most-cited papers

Significant Association Between Low Baseline Neutrophil‐to‐Lymphocyte Ratio and Improved Progression‐free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab‐Paclitaxel
Yoshimasa Miyagawa, K. Araki, A. Bun, Hiromi Ozawa +7 more
2018Clinical Breast Cancer54 citations Open access
Semantic Scholar
Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel
K. Araki, Y. Ito, I. Fukada, K. Kobayashi +8 more
2018BMC Cancer54 citations Open access
Semantic Scholar
High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
A. Nishimukai, T. Yagi, Ayako Yanai, Yoshimasa Miyagawa +7 more
2015Clinical Breast Cancer51 citations
Semantic Scholar
Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine
M. Imamura, T. Morimoto, C. Egawa, Reiko Fukui +6 more
2019Scientific Reports42 citations Open access
Semantic Scholar
Prognostic significance of preoperative 18F-FDG PET/CT for breast cancer subtypes.
Tomoko Higuchi, A. Nishimukai, Hiromi Ozawa, Yukie Fujimoto +8 more
2016Breast38 citations Open access
Semantic Scholar
Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers
Yukie Fujimoto, Takahiro Watanabe, A. Hida, Tomoko Higuchi +8 more
2019Breast Cancer33 citations
Semantic Scholar
Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes
M. Imamura, T. Morimoto, T. Nomura, S. Michishita +12 more
2018World Journal of Surgical Oncology29 citations Open access
Semantic Scholar
Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers
Y. Enomoto, T. Morimoto, A. Nishimukai, Tomoko Higuchi +10 more
2016International Journal of Clinical Oncology27 citations
Semantic Scholar
Improved prognosis of low baseline neutrophil-to-lymphocyte ratio is significantly exclusive in breast cancer patients with high absolute counts of lymphocytes.
Yukie Fujimoto, Hiromi Ozawa, Tomoko Higuchi, Yoshimasa Miyagawa +3 more
2018Molecular and clinical oncology26 citations Open access
Semantic Scholar
Prognostic Significance of Neutrophil-to-lymphocyte Ratio in Luminal Breast Cancers With Low Levels of Tumour-infiltrating Lymphocytes
A. Bun, Yukie Fujimoto, Tomoko Higuchi, Atsushi Sata +6 more
2020Anticancer Research22 citations Open access
Semantic Scholar
Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in 18F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative Chemotherapy
Tomoko Higuchi, Yukie Fujimoto, Hiromi Ozawa, A. Bun +6 more
2019Annals of Surgical Oncology22 citations Open access
Semantic Scholar
Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer
Yoshimasa Miyagawa, Ayako Yanai, Takehiro Yanagawa, J. Inatome +17 more
2020OncoTarget19 citations Open access
Semantic Scholar
C-Reactive Protein and Absolute Lymphocyte Count Can Predict Overall Survival of Patients Treated With Eribulin
Atsushi Sata, Reiko Fukui, Yoshimasa Miyagawa, A. Bun +5 more
2020Anticancer Research19 citations Open access
Semantic Scholar
Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women
Yoshimasa Miyagawa, T. Miyake, Ayako Yanai, K. Murase +12 more
2015Breast Cancer18 citations
Semantic Scholar
Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers
Ayako Yanai, Yoshimasa Miyagawa, K. Murase, M. Imamura +8 more
2013International Journal of Clinical Oncology18 citations
Semantic Scholar
Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer.
Ayako Yanai, N. Inoue, T. Yagi, A. Nishimukai +10 more
2015Clinical Breast Cancer15 citations
Semantic Scholar
Biological characteristics of luminal subtypes in pre- and postmenopausal estrogen receptor-positive and HER2-negative breast cancers
K. Murase, Ayako Yanai, Masaru Saito, M. Imamura +13 more
2012Breast Cancer14 citations
Semantic Scholar
High levels of serum CA15‐3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non‐pathological complete response after neoadjuvant chemotherapy
Yukie Fujimoto, Tomoko Higuchi, A. Nishimukai, Yoshimasa Miyagawa +5 more
2018Journal of Surgical Oncology13 citations
Semantic Scholar
Frequent downregulation of LRRC26 by epigenetic alterations is involved in the malignant progression of triple-negative breast cancer.
Yoshimasa Miyagawa, Y. Matsushita, Hiromu Suzuki, M. Komatsu +8 more
2018International Journal of Oncology13 citations Open access
Semantic Scholar
Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers
T. Yagi, N. Inoue, Ayako Yanai, K. Murase +8 more
2016Breast Cancer12 citations
Semantic Scholar
C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis
T. Miyake, Takashi Ito, Ayako Yanai, N. Inoue +11 more
2015Breast Cancer9 citations
Semantic Scholar
Serum Prostate‐Specific Antigen Values for the Prediction of Clinical Stage and Prognosis in Patients with Prostate Cancer: An Analysis of 749 Cases
M. Kuriyama, K. Obata, Yoshimasa Miyagawa, E. Nishikawa +6 more
1996International journal of urology9 citations Open access
Semantic Scholar
A Single-centre, Retrospective, Observational Analysis of Fulvestrant for Recurrent/metastatic Breast Cancer According to Metastatic Site
Hiromi Ozawa, Atsushi Sata, Reiko Fukui, A. Bun +5 more
2019Anticancer Research8 citations Open access
Semantic Scholar
Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases
A. Nishimukai, Tomoko Higuchi, Hiromi Ozawa, Ayako Yanai +5 more
2017Breast Cancer8 citations
Semantic Scholar
High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients
M. Imamura, A. Nishimukai, Tomoko Higuchi, Hiromi Ozawa +8 more
2015Breast Cancer Research and Treatment7 citations
Semantic Scholar
Response-Guided Omission of Anthracycline in Patients with HER2-Positive Early Breast Cancer Treated with Neoadjuvant Taxane and Trastuzumab: 5-Year Follow-Up of Prognostic Study Using Propensity Score Matching
N. Fujita, Koichi Fujita, Seung-Jin Kim, C. Iguchi +9 more
2022Oncology4 citations
Semantic Scholar
Activation of mTOR / S 6 K But Not MAPK Pathways Might Be Associated With High Ki-67 , ER þ , and HER 2 Breast Cancer
Ayako Yanai, N. Inoue, T. Yagi, A. Nishimukai +10 more
4 citations
Semantic Scholar
Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report
Keiko Inakami, N. Fujita, C. Iguchi, Y. Enomoto +10 more
2024Journal of Medical Case Reports1 citations Open access
Semantic Scholar
A case of pathological complete response of advanced rectal cancer to preoperative chemoradiotherapy using S-1.
H. Tanishima, T. Horiuchi, K. Tamagawa, Takehiro Tsujimoto +8 more
2010Gan to kagaku ryoho. Cancer & chemotherapy1 citations
Semantic Scholar
[Clinical evaluation of sultamicillin in the treatment of urinary tract infections].
H. Fukatsu, Hitoshi Noonmura, Yoshimasa Miyagawa, M. Waki +5 more
1990Hinyokika kiyo. Acta urologica Japonica1 citations
Semantic Scholar
Abstract PS4-20: Low levels of interleukin-6 at baseline were significantly associated with improved overall survival of patients treated with eribulin for locally advanced or metastatic breast cancer
A. Bun, N. Inoue, Yoshimasa Miyagawa, Reiko Fukui +6 more
20210 citations
Semantic Scholar
Abstract P3-08-30: Low levels of metabolic tumor volume at baseline significantly associated with longer progression-free survival in patients with locally advanced or metastatic breast cancer treated with endocrine therapies
Reiko Fukui, Tomoko Higuchi, Yukie Fujimoto, Atsushi Sata +6 more
2020Poster Session Abstracts0 citations
Semantic Scholar
Abstract P3-08-49: Baseline neutrophil-to-lymphocyte ratio and C-reactive protein predict efficacy of bevacizumab plus paclitaxel therapy for locally advanced or metastatic breast cancer
Hiromi Ozawa, Yoshimasa Miyagawa, Ayako Yanai, Takehiro Yanagawa +12 more
20200 citations
Semantic Scholar
Abstract P3-10-19: Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive locally advanced and metastatic breast cancer treated with trastuzumab emtansine
M. Imamura, T. Morimoto, C. Egawa, Yoshimasa Miyagawa +1 more
2019Poster Session Abstracts0 citations
Semantic Scholar
Abstract P2-09-31: Predictive impact of absolute lymphocyte counts for progression-free survival in HER2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel
K. Araki, Y. Ito, I. Fukada, K. Kobayashi +8 more
20180 citations
Semantic Scholar
Abstract P2-05-27: Baseline serum CA15-3 levels are associated with prognosis for breast cancer patients with non-complete pathological response to neoadjuvant chemotherapy
Yukie Fujimoto, M. Imamura, Tomoko Higuchi, A. Nishimukai +5 more
20170 citations
Semantic Scholar
Abstract P2-08-24: High levels of serum C-terminal crosslinking telopeptide of type 1 collagen at baseline are associated with poor prognosis for breast cancer patients
M. Imamura, A. Nishimikai, Ayako Yanai, Yoshimasa Miyagawa +5 more
20160 citations
Semantic Scholar
Abstract P6-16-01: Differences in patterns of change of bone turnover markers during treatment with bone-modifying agents of breast cancer patients with bone metastases
Tomoko Higuchi, A. Nishimukai, Ayako Yanai, Yoshimasa Miyagawa +5 more
20160 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Imamura×32
Invite
M. Imamura — researcher profile on SciRah
Y. Miyoshi×31
Invite
Y. Miyoshi — researcher profile on SciRah
Tomoko Higuchi×21
Invite
Tomoko Higuchi — researcher profile on SciRah
Y. Takatsuka×19
Invite
Y. Takatsuka — researcher profile on SciRah

×18

Invite

Hiromi Ozawa — researcher profile on SciRah

Ayako Yanai×18

Invite

Ayako Yanai — researcher profile on SciRah

Yukie Fujimoto×16

Invite

Yukie Fujimoto — researcher profile on SciRah

Invite

K. Murase — researcher profile on SciRah

A. Nishimukai×15

Invite

A. Nishimukai — researcher profile on SciRah

Invite

A. Bun — researcher profile on SciRah

Reiko Fukui×10

Invite

Reiko Fukui — researcher profile on SciRah

Atsushi Sata×9

Invite

Atsushi Sata — researcher profile on SciRah